Carbapenem-Resistant Klebsiella Pneumoniae in Iran: a Systematic Review and Meta-Analysis

被引:19
作者
Vaez, Hamid [1 ]
Sahebkar, Amirhossein [2 ,3 ,4 ]
Khademi, Farzad [5 ]
机构
[1] Zabol Univ Med Sci, Sch Med, Dept Microbiol, Zabol, Iran
[2] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran
[3] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[4] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran
[5] Ardabil Univ Med Sci, Sch Med, Dept Microbiol, Ardebil, Iran
关键词
K; pneumoniae; Carbapenem; Antibiotic resistance; Iran; SPECTRUM BETA-LACTAMASE; HOSPITALIZED-PATIENTS; 1ST REPORT; PREVALENCE; ENTEROBACTERIACEAE; INTEGRONS; NDM-1; PCR;
D O I
10.1080/1120009X.2018.1533266
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The global emergence and dissemination of carbapenem-resistant (CR)-Klebsiella pneumoniae is an important healthcare concern owing to the limited therapeutic options that are available. The aim of the present study was to evaluate the prevalence of CR K. pneumoniae in different parts of Iran. A comprehensive literature search was performed in national and international databases. After applying predefined inclusion and exclusion criteria, 36 articles reporting prevalence of CR K. pneumoniae were collected. The pooled prevalence of CR K. pneumoniae was estimated to be 11.3% (95% CI: 0.084-0.15). The highest and lowest prevalence rates of CR K. pneumoniae were in Isfahan 58% (95% CI: 0.48-0.67) and Tehran 0.004 (95% CI: 0.00-0.05), respectively. The highest and lowest resistance rates were seen against aztreonam (55%, 95% CI: 0.48-0.62) and amikacin (23%, (95% CI: 0.17-0.29), respectively. The findings of the present study revealed that the prevalence of CR K. pneumoniae is alarmingly high in the majority of Iranian hospitals.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 57 条
[31]  
Khodadadian R, 2017, FEYZ J KASHAN U MED, V21, P390
[32]  
Kiani-Abari P, 2015, J SHAHREKORD U MED, V17, P121
[33]  
Langarizadeh N, 2010, Q J ANIM PHYSL DEV, V4, P17
[34]   Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods [J].
Lee, Chang-Ro ;
Lee, Jung Hun ;
Park, Kwang Seung ;
Kim, Young Bae ;
Jeong, Byeong Chul ;
Lee, Sang Hee .
FRONTIERS IN MICROBIOLOGY, 2016, 7
[35]   Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore [J].
Ling, Moi Lin ;
Tee, Yong Ming ;
Tan, Soong Geck ;
Amin, Ismawati M. ;
How, Kue Bien ;
Tan, Kwee Yuen ;
Lee, Lai Chee .
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2015, 4
[36]   The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace [J].
Logan, Latania K. ;
Weinstein, Robert A. .
JOURNAL OF INFECTIOUS DISEASES, 2017, 215 :S28-S36
[37]  
Mansouri S, 2014, JUNDISHAPUR J MICROB, V7, P1
[38]   Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae [J].
Martin, Rebekah M. ;
Bachman, Michael A. .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
[39]   Carbapenem resistance: overview of the problem and future perspectives [J].
Meletis, Georgios .
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2016, 3 (01) :15-21
[40]   Integron mediated multidrug resistance in extended spectrum beta-lactamase producing clinical isolates of Klebsiella pneumoniae [J].
Mobarak-Qamsari, Maryam ;
Ashayeri-Panah, Mitra ;
Eftekhar, Freshteh ;
Feizabadi, Mohammad Mehdi .
BRAZILIAN JOURNAL OF MICROBIOLOGY, 2013, 44 (03) :849-854